01.21.2026

SonoMotion announces FDA 510(k) clearance of it’s Break Wave™ lithotripsy device for the non-invasive and anesthesia free treatment of kidney stones.

04.23.2025

SonoMotion completed enrollment in the SOUND Break Wave™ pivotal clinical trial.

02.28.2025

SonoMotion secures a $2.2M Fastrack NIH SBIR grant to fund future Break Wave™ milestones.

11.13.2024

SonoMotion announces FDA de-novo clearance of it’s Stone Clear™ device

09.10.2024

Break Wave™ First-in-Human Multicenter Clinical Trial publication selected as the cover article of the Journal of Urology, October 2024 issue. (Article PDF, Journal of Urology Press Release, Infographic Result Summary PPT Download)

08.16.2024

Ultrasound propulsion reduces relapse rate incidence by 70% in patients with post-lithotripsy residual fragments as shown in the University of Washington randomized controlled trial published in Journal of Urology (Article PDF, Urology Times Interview)